C12N 2810/6036
Dna rev transcr viruses
Official title: DNA rev transcr viruses
C12N2810/6036 (Dna rev transcr viruses) appears on 2 US grants and 2 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 2
- Assignees
- 3
- Inventors
- 5
- Latest grant
- 16 Jan 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
By publication year.
Recent patents
- Hydrophobic modified pres-derived peptides of hepatitis B virus (HBV) and their use as vehicles for the specific delivery of compounds to the liver16 Jan 2018US 9,868,768 B2Ruprecht-Karls-UniversitäT Heidelberg
- Hepatitis B virus compositions and methods of use10 Jun 2014US 8,748,373 B2Fox Chase Cancer Center
- Hepatitis B Virus Compositions and Methods of Use20 Oct 2011US 2011/0257080 A1Fox Chase Cancer Center
- Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver3 Feb 2011US 2011/0027183 A1Ruprecht-Karls-UniversitäT Heidelberg
Most cited
By later US patents